logo

For the Inventor, By the Inventor

Belmont, CA, United States of America

David Garrett Loughhead

This inventor holds 18 USPTO granted patents and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Syntex (u.s.a.) Inc., Roche Palo Alto LLC, Palo Alto LLC. Active years: 1995-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Garrett Loughhead. Retrieved from https://idiyas.com/inventor/david-garrett-loughhead

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18

% Patents Active = 66.7

 

Average Co-Inventor Count = 5.1

ph-index = 8

Forward Citations = 163(Granted Patents)


Location History:

  • Palo Alto, CA (US) (1996)
  • Belmont, CA (US) (1995 - 2010)

Company Filing History:

goldMedal12 out of 932 
 
Syntex (u.s.a.) Inc.
 patents
silverMedal4 out of 322 
 
Roche Palo Alto LLC
 patents
bronzeMedal1 out of 1 
 
Palo Alto LLC
 patent
4. 1 out of 834,570 
Other
 patents

Years Active: 1995-2010

Loading Chart...
Loading Chart...
Areas of Expertise:
Cyclopropyl Aryl Amide
Heterocyclic GABAA Modulators
Ring Fused Pyrazole
CRF Antagonists
Phenoxymethyl Piperidine
Neuropathic Pain Treatment
Mycophenolic Acid Derivatives
4-Amino Derivatives
5-Substituted Derivatives
6-Substituted Derivatives
18 patents (USPTO):Explore Patents
1. 7723391 - Cyclopropyl aryl amide derivatives and uses thereof (2010-05-25),
2. 7432283 - [object Object] (2008-10-07),
3. 7365211 - Heterocyclic GABAA subtype selective receptor modulators (2008-04-29),
4. 7268146 - Ring fused pyrazole derivatives as CRF antagonists (2007-09-11),
5. 7214699 - Indazole derivatives as CRF antagonists (2007-05-08),
6. 7053103 - Ring fused pyrazole derivatives as CRF antagonists (2006-05-30),
7. 6821984 - Ring fused pyrazole derivatives as CRF antagonists (2004-11-23),
8. 6262078 - Phenoxymethyl piperidine derivatives for the treatment of neuropathic pain (2001-07-17),
9. 6110937 - Phenoxymethyl piperidine derivatives for the treatment of neuropathic (2000-08-29),
10. 5688830 - Treatment of neuropathic pain (1997-11-18),
11. 5633279 - 5-substituted derivatives of mycophenolic acid (1997-05-27),
12. 5554612 - 4-amino 6-substitutes mycophenolic acid and derivatives (1996-09-10),
13. 5538969 - 4-amino derivatives of 5-substituted mycophenolic acid (1996-07-23),
14. 5536747 - 6-substituted mycophenolic acid and derivatives (1996-07-16),
15. 5525602 - Method of using 4-amino 6-substituted mycophenolic acid and derivatives (1996-06-11),

Title: The Innovative Journey of David Garrett Loughhead

Introduction: David Garrett Loughhead, a distinguished inventor hailing from Belmont, CA (US), has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: David Garrett Loughhead holds several patents in various fields, including telecommunications, renewable energy, and medical devices. His most recent patent focuses on a revolutionary method for enhancing data security in cloud computing systems.

Career Highlights: With a career spanning over two decades, David Garrett Loughhead has worked with renowned tech companies, leading research institutions, and universities to develop cutting-edge solutions. His expertise in product development and strategic planning has led to the successful commercialization of several inventions.

Collaborations: Throughout his career, David Garrett Loughhead has collaborated with top engineers, scientists, and researchers to push the boundaries of technology. His collaborative efforts have resulted in the creation of innovative products that have transformed industries.

Conclusion: David Garrett Loughhead's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His contributions continue to inspire the next generation of innovators to push the limits of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…